These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 991901)

  • 41. Podophyllotoxin derivatives.
    D'Incalci M; Garattini S
    Cancer Chemother Biol Response Modif; 1992; 13():75-82. PubMed ID: 1389926
    [No Abstract]   [Full Text] [Related]  

  • 42. Response of L1210 leukemia to treatment with 1,3-bis(2-chloroethyl)-1-nitrosourea plus 4'-demethylepipodophyllotoxin-9-(4,6-O-2-thenylidene-beta-D-glucopyranoside).
    Roberts D; Peck C; Hilliard S; Karas JG
    Cancer Res; 1981 Oct; 41(10):3891-5. PubMed ID: 7284998
    [No Abstract]   [Full Text] [Related]  

  • 43. [Action of alkaloids from podophyllin on the response of pancreatic beta-cells of the rabbit to tolbutamide].
    Gónzalez Larriba JL; Picaporte MA; Grande C; Gasalla Chacón R; Montero García JM
    Rev Esp Oncol; 1983; 30(4):485-90. PubMed ID: 6400620
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The role of drug disposition kinetics on cellular transport of the antineoplastic agent VM-26.
    Allen L
    Drug Metab Rev; 1978; 8(1):119-35. PubMed ID: 720213
    [No Abstract]   [Full Text] [Related]  

  • 45. Reversal of etoposide resistance in non-P-glycoprotein expressing multidrug resistant tumor cell lines by novobiocin.
    Rappa G; Lorico A; Sartorelli AC
    Cancer Res; 1993 Nov; 53(22):5487-93. PubMed ID: 8106148
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduced formation of lesions in the DNA of a multidrug-resistant L1210 subline selected for teniposide resistance.
    Roberts DW; Foglesong PD; Parganas E; Wiggins L
    Cancer Chemother Pharmacol; 1989; 23(3):161-8. PubMed ID: 2538249
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Radioimmunoassay for etoposide and teniposide.
    Ho DH; Kanellopoulos KS; Brown NS; Issell BF; Bodey GP
    J Immunol Methods; 1985 Dec; 85(1):5-15. PubMed ID: 4078312
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Teniposide and etoposide in previously untreated small-cell lung cancer: a randomized study.
    Bork E; Ersbøll J; Dombernowsky P; Bergman B; Hansen M; Hansen HH
    J Clin Oncol; 1991 Sep; 9(9):1627-31. PubMed ID: 1651994
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Verapamil potentiation of VP-16-213 in acute lymphatic leukemia and reversal of pleiotropic drug resistance.
    Slater LM; Murray SL; Wetzel MW; Sweet P; Stupecky M
    Cancer Chemother Pharmacol; 1986; 16(1):50-4. PubMed ID: 3455667
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tests for the genotoxicity of m-AMSA, etoposide, teniposide and ellipticine in Neurospora crassa.
    Gupta R
    Mutat Res; 1990 Feb; 240(2):47-58. PubMed ID: 2137196
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute myeloid leukemia in children treated with epipodophyllotoxins for acute lymphoblastic leukemia.
    Pui CH; Ribeiro RC; Hancock ML; Rivera GK; Evans WE; Raimondi SC; Head DR; Behm FG; Mahmoud MH; Sandlund JT
    N Engl J Med; 1991 Dec; 325(24):1682-7. PubMed ID: 1944468
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis, 470-MHz 1H NMR spectra, and activity of delactonized derivatives of the anticancer drug etoposide.
    Jardine I; Strife RJ; Kozlowski J
    J Med Chem; 1982 Sep; 25(9):1077-81. PubMed ID: 7131486
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Peroxidative free radical formation and O-demethylation of etoposide(VP-16) and teniposide(VM-26).
    Haim N; Roman J; Nemec J; Sinha BK
    Biochem Biophys Res Commun; 1986 Feb; 135(1):215-20. PubMed ID: 3006680
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Analysis of the anticancer drugs etoposide (VP 16-213) and teniposide (VM 26) by high-performance liquid chromatography with fluorescence detection.
    Strife RJ; Jardine I; Colvin M
    J Chromatogr; 1981 Jun; 224(1):168-74. PubMed ID: 7263816
    [No Abstract]   [Full Text] [Related]  

  • 55. [Antitumor effect of etoposide and its analogs].
    Kuramochi H; Okamoto K; Nishikawa K; Nagamine S; Takahashi K
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2196-201. PubMed ID: 4062319
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of dose, schedule, and route of administration on the in vivo toxicity and antitumor activity of two activated sulfhydryl derivatives of cyclophosphamide.
    Ramonas LM; Erickson LC; Ringsdorf H; Zaharko DS
    Cancer Res; 1980 Oct; 40(10):3704-8. PubMed ID: 7438053
    [TBL] [Abstract][Full Text] [Related]  

  • 57. DNA minor groove binding agents interfere with topoisomerase II mediated lesions induced by epipodophyllotoxin derivative VM-26 and acridine derivative m-AMSA in nuclei from L1210 cells.
    Woynarowski JM; Sigmund RD; Beerman TA
    Biochemistry; 1989 May; 28(9):3850-5. PubMed ID: 2473776
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Characterization of VP-16-induced DNA damage in isolated nuclei from L1210 cells.
    Glisson BS; Smallwood SE; Ross WE
    Biochim Biophys Acta; 1984 Oct; 783(1):74-9. PubMed ID: 6477925
    [TBL] [Abstract][Full Text] [Related]  

  • 59. DNA damage as a basis for 4'-demethylepipodophyllotoxin-9-(4,6-O-ethylidene-beta-D-glucopyranoside) (etoposide) cytotoxicity.
    Wozniak AJ; Ross WE
    Cancer Res; 1983 Jan; 43(1):120-4. PubMed ID: 6847761
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Timing- and sequence-dependent synergism between etoposide and methotrexate or etoposide, methotrexate and 5-fluorouracil in advanced leukemia L1210.
    Osswald H; Herrmann R; Youssef M
    Cancer Lett; 1985 Dec; 29(3):277-82. PubMed ID: 4075296
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.